297 related articles for article (PubMed ID: 26101067)
1. Galectin-3 and post-myocardial infarction cardiac remodeling.
Meijers WC; van der Velde AR; Pascual-Figal DA; de Boer RA
Eur J Pharmacol; 2015 Sep; 763(Pt A):115-21. PubMed ID: 26101067
[TBL] [Abstract][Full Text] [Related]
2. Integration of "omics" techniques: Dronedarone affects cardiac remodeling in the infarction border zone.
Chilukoti RK; Lendeckel J; Darm K; Bukowska A; Goette A; Sühling M; Utpatel K; Peters B; Homuth G; Völker U; Wolke C; Scharf C; Lendeckel U
Exp Biol Med (Maywood); 2018 Jul; 243(11):895-910. PubMed ID: 30105952
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.
Frunza O; Russo I; Saxena A; Shinde AV; Humeres C; Hanif W; Rai V; Su Y; Frangogiannis NG
Am J Pathol; 2016 May; 186(5):1114-27. PubMed ID: 26948424
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression in cardiac remodeling after myocardial infarction.
Sanchez-Mas J; Lax A; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor F; Januzzi JL; Pascual-Figal DA
Int J Cardiol; 2014; 172(1):e98-e101. PubMed ID: 24433619
[No Abstract] [Full Text] [Related]
5. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
6. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades.
Wang X; Gaur M; Mounzih K; Rodriguez HJ; Qiu H; Chen M; Yan L; Cooper BA; Narayan S; Derakhshandeh R; Rao P; Han DD; Nabavizadeh P; Springer ML; John CM
Cardiovasc Res; 2023 Nov; 119(15):2536-2549. PubMed ID: 37602717
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 is expressed in the myocardium very early post-myocardial infarction.
Hashmi S; Al-Salam S
Cardiovasc Pathol; 2015; 24(4):213-23. PubMed ID: 25547609
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
10. Genetic Deletion of Galectin-3 Alters the Temporal Evolution of Macrophage Infiltration and Healing Affecting the Cardiac Remodeling and Function after Myocardial Infarction in Mice.
Cassaglia P; Penas F; Betazza C; Fontana Estevez F; Miksztowicz V; Martínez Naya N; Llamosas MC; Noli Truant S; Wilensky L; Volberg V; Cevey ÁC; Touceda V; Cicale E; Berg G; Fernández M; Goren N; Morales C; González GE
Am J Pathol; 2020 Sep; 190(9):1789-1800. PubMed ID: 32473918
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.
Asensio-Lopez MDC; Lax A; Fernandez Del Palacio MJ; Sassi Y; Hajjar RJ; Pascual-Figal DA
Transl Res; 2018 Sep; 199():4-23. PubMed ID: 29753686
[TBL] [Abstract][Full Text] [Related]
12. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction.
Sanchez-Mas J; Lax A; Asensio-Lopez MC; Lencina M; Fernandez-Del Palacio MJ; Soriano-Filiu A; de Boer RA; Pascual-Figal DA
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):460-469. PubMed ID: 28718055
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice.
González GE; Cassaglia P; Noli Truant S; Fernández MM; Wilensky L; Volberg V; Malchiodi EL; Morales C; Gelpi RJ
Int J Cardiol; 2014 Oct; 176(3):1423-5. PubMed ID: 25150483
[No Abstract] [Full Text] [Related]
14. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model.
Vlachou F; Varela A; Stathopoulou K; Ntatsoulis K; Synolaki E; Pratsinis H; Kletsas D; Sideras P; Davos CH; Capetanaki Y; Psarras S
Cell Mol Life Sci; 2022 Apr; 79(5):250. PubMed ID: 35441327
[TBL] [Abstract][Full Text] [Related]
15. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
Van Aelst LN; Voss S; Carai P; Van Leeuwen R; Vanhoutte D; Sanders-van Wijk S; Eurlings L; Swinnen M; Verheyen FK; Verbeken E; Nef H; Troidl C; Cook SA; Brunner-La Rocca HP; Möllmann H; Papageorgiou AP; Heymans S
Circ Res; 2015 Jan; 116(3):425-36. PubMed ID: 25520363
[TBL] [Abstract][Full Text] [Related]
16. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
17. Value of Galectin-3 in Acute Myocardial Infarction.
Li M; Yuan Y; Guo K; Lao Y; Huang X; Feng L
Am J Cardiovasc Drugs; 2020 Aug; 20(4):333-342. PubMed ID: 31784887
[TBL] [Abstract][Full Text] [Related]
18. Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.
Sharma UC; Mosleh W; Chaudhari MR; Katkar R; Weil B; Evelo C; Cimato TR; Pokharel S; Blankesteijn WM; Suzuki G
Heart Lung Circ; 2017 Jul; 26(7):736-745. PubMed ID: 28094123
[TBL] [Abstract][Full Text] [Related]
19. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
Mewhort HE; Turnbull JD; Meijndert HC; Ngu JM; Fedak PW
J Thorac Cardiovasc Surg; 2014 May; 147(5):1650-9. PubMed ID: 24075463
[TBL] [Abstract][Full Text] [Related]
20. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
